-
Rocket Pharmaceuticals (NASDAQ:RCKT) Receives "Buy" Rating from Needham & Company LLC
Source: Buzz FX / 08 Nov 2024 09:41:17 America/New_York
Rocket Pharmaceuticals (NASDAQ:RCKT) Receives "Buy" Rating from Needham & Company LLC Written by MarketBeat November 8, 2024 Share Link copied to clipboard. Rocket Pharmaceuticals ( NASDAQ:RCKT - Get Free Report ) 's stock had its "buy" rat
Read more...